deltatrials
Terminated PHASE2 INTERVENTIONAL NCT00058448

S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

Phase II Study Of Weekly Docetaxel In Patients With Advanced Epidermoid Carcinoma Of The Penis

Sponsor: Eastern Cooperative Oncology Group

Conditions Penile Cancer
Interventions docetaxel
Updated 8 times since 2017 Last updated: Jun 27, 2018 Started: Oct 31, 2004 Primary completion: Nov 30, 2005 Completion: Nov 30, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated due to poor patient recruitment.

Other terminated trials from Eastern Cooperative Oncology Group

More terminations from Eastern Cooperative Oncology Group

Listed as NCT00058448, this PHASE2 trial focuses on Penile Cancer and remains terminated or withdrawn. Sponsored by Eastern Cooperative Oncology Group, it has been updated 8 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotTerminated~Jul 2018 – ~Jan 2021 · 30 months · monthly snapshotTerminated~Jan 2021 – ~May 2023 · 28 months · monthly snapshotTerminated~May 2023 – ~Jul 2024 · 14 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. May 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — May 2023 [monthly]

    Terminated PHASE2

  5. Jul 2018 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Jul 2018 [monthly]

    Terminated PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eastern Cooperative Oncology Group
  • National Cancer Institute (NCI)
  • SWOG Cancer Research Network
Data source: SWOG Cancer Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anderson, United States , Ann Arbor, United States , Billings, United States , Bozeman, United States , Butte, United States , Chillicothe, United States , Cleveland, United States , Columbus, United States , Delaware, United States , Denver, United States and 24 more locations